Abstract | BACKGROUND: Radiation recall is a recurrence of acute toxicity within a previously quiescent radiation field that occurs with subsequent administration of chemotherapy. METHODS: RESULTS: Two skin sites developed erythema and dry desquamation 18 days after completion of radiation therapy to a dose of 40 Gy in 20 fractions. These reactions took place after the second dose of bleomycin administered intravenously on a weekly basis. The reactions were exacerbated by oral etoposide therapy, which was started 4 days after the recall phenomenon was noted. Other cutaneous sites treated with 8 Gy in a single fraction and 20 Gy in ten fractions during the same time period showed no sign of recall skin toxicity. CONCLUSIONS: The authors believe this to be the first report of radiation recall toxicity after bleomycin therapy and of a radiation dose response related to this phenomenon. The potential for radiation recall toxicity should be considered in treatment decisions pertaining to patients with AIDS-associated KS.
|
Authors | K J Stelzer, T W Griffin, W J Koh |
Journal | Cancer
(Cancer)
Vol. 71
Issue 4
Pg. 1322-5
(Feb 15 1993)
ISSN: 0008-543X [Print] United States |
PMID | 7679610
(Publication Type: Case Reports, Clinical Trial, Journal Article, Randomized Controlled Trial)
|
Chemical References |
|
Topics |
- AIDS-Related Opportunistic Infections
(drug therapy, radiotherapy)
- Adult
- Bleomycin
(adverse effects, therapeutic use)
- Combined Modality Therapy
- Humans
- Male
- Mouth Neoplasms
(drug therapy)
- Neoplasms, Multiple Primary
(drug therapy, radiotherapy)
- Radiotherapy Dosage
- Radiotherapy, High-Energy
- Sarcoma, Kaposi
(drug therapy, radiotherapy)
- Skin
(drug effects, radiation effects)
- Skin Neoplasms
(drug therapy, radiotherapy)
|